Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

Clinical trial NCT03604991 · SUSPENDED

Trial details

NCT number: NCT03604991
Sponsor: National Cancer Institute (NCI)
Status: SUSPENDED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Clinical Stage II Esophageal Adenocarcinoma AJCC v8 Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage III Esophageal Adenocarcinoma AJCC v8 Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 Esophageal Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2019-05-03
Primary completion: 2026-12-31
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.